Guidelines: The National Clinical Cancer Care Guidelines (Sweden): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 7: Line 7:
'''Sponsor, manager or home institution:''' The National Clinical Cancer Care.
'''Sponsor, manager or home institution:''' The National Clinical Cancer Care.


'''Type of information:''' Recommendations, treatments, [[availableVariable::medical procedures]], rehabilitation, [[availableVariable::palliative care]], [[availableVariable::quality of life]], [[availableVariable::medication use]], [[availableVariable::check-up examinations]] and follow-up of patients with  various types of cancer.
'''Type of information:''' Recommendations, [[availableVariable::screening]], [[availableVariable::diagnosis]], treatments, [[availableVariable::medical procedures]], rehabilitation, [[availableVariable::palliative care]], [[availableVariable::quality of life]], [[availableVariable::medication use]], [[availableVariable::check-up examinations]] and follow-up of patients with  various types of cancer.  


'''Cancer areas of interest:''' [[hasCancerType::C00-D48: All neoplasms]].
'''Cancer areas of interest:''' [[hasCancerType::C00-D48: All neoplasms]].


'''Access to information:''' [https://kunskapsbanken.cancercentrum.se/vardprogram/ Click here to access].
'''Access to information:''' [https://kunskapsbanken.cancercentrum.se/vardprogram/ Click here to access].

Revision as of 17:05, 26 June 2024

Go back to Sweden page

Primary purpose: To ensure equal and high-quality care for all patients by providing evidence-based recommendations on the investigation, treatment, nursing, rehabilitation, and follow-up of patients with cancer.

Sponsor, manager or home institution: The National Clinical Cancer Care.

Type of information: Recommendations, screening, diagnosis, treatments, medical procedures, rehabilitation, palliative care, quality of life, medication use, check-up examinations and follow-up of patients with various types of cancer.

Cancer areas of interest: C00-D48: All neoplasms.

Access to information: Click here to access.